Literature DB >> 29845480

Symposium Title: Preference Evidence for Regulatory Decisions.

Juan Marcos Gonzalez1, F Reed Johnson2, Bennett Levitan3, Rebecca Noel4, Holly Peay5.   

Abstract

Mesh：

Year:  2018        PMID： 29845480     DOI： 10.1007/s40271-018-0311-y

Source DB:  PubMed          Journal:  Patient        ISSN： 1178-1653            Impact factor:   3.883


× No keyword cloud information.
  22 in total

1.  Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008.

Authors:  Deborah Marshall; John F P Bridges; Brett Hauber; Ruthanne Cameron; Lauren Donnalley; Ken Fyie; F Reed Johnson
Journal:  Patient       Date:  2010-12-01       Impact factor: 3.883

2.  Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.

Authors:  Bernard Escudier; Camillo Porta; Petri Bono; Thomas Powles; Tim Eisen; Cora N Sternberg; Jürgen E Gschwend; Ugo De Giorgi; Omi Parikh; Robert Hawkins; Emmanuel Sevin; Sylvie Négrier; Sadya Khan; Jose Diaz; Suman Redhu; Faisal Mehmud; David Cella
Journal:  J Clin Oncol       Date:  2014-03-31       Impact factor: 44.544

3.  Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.

Authors:  John F P Bridges; A Brett Hauber; Deborah Marshall; Andrew Lloyd; Lisa A Prosser; Dean A Regier; F Reed Johnson; Josephine Mauskopf
Journal:  Value Health       Date:  2011-04-22       Impact factor: 5.725

4.  Giving Patients' Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public-Private Project.

Authors:  Esther W de Bekker-Grob; Conny Berlin; Bennett Levitan; Karim Raza; Kalliopi Christoforidi; Irina Cleemput; Jana Pelouchova; Harald Enzmann; Nigel Cook; Mats G Hansson
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

5.  Key Issues and Potential Solutions for Understanding Healthcare Preference Heterogeneity Free from Patient-Level Scale Confounds.

Authors:  Catharina G M Groothuis-Oudshoorn; Terry N Flynn; Hong Il Yoo; Jay Magidson; Mark Oppe
Journal:  Patient       Date:  2018-10       Impact factor: 3.883

6.  Incorporating patient preferences into drug development and regulatory decision making: Results from a quantitative pilot study with cancer patients, carers, and regulators.

Authors:  D Postmus; M Mavris; H L Hillege; T Salmonson; B Ryll; A Plate; I Moulon; H-G Eichler; N Bere; F Pignatti
Journal:  Clin Pharmacol Ther       Date:  2016-02-17       Impact factor: 6.875

7.  Caregiver preferences for emerging duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis.

Authors:  Ilene L Hollin; Holly L Peay; John F P Bridges
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

8.  A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies.

Authors:  Martin Ho; Anindita Saha; K Kimberly McCleary; Bennett Levitan; Stephanie Christopher; Kristen Zandlo; R Scott Braithwaite; A Brett Hauber
Journal:  Value Health       Date:  2016 Sep - Oct       Impact factor: 5.725

Review 9.  Discrete choice experiments in health economics: a review of the literature.

Authors:  Esther W de Bekker-Grob; Mandy Ryan; Karen Gerard
Journal:  Health Econ       Date:  2010-12-19       Impact factor: 3.046

10.  FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga.

Authors:  Annemieke Aartsma-Rus; Arthur M Krieg
Journal:  Nucleic Acid Ther       Date:  2016-12-08       Impact factor: 5.486
View more
  7 in total

1.  Support Tools for Preference-Sensitive Decisions in Healthcare: Where Are We? Where Do We Go? How Do We Get There?

Authors:  Jan Ostermann; Derek S Brown; Janine A van Til; Nick Bansback; France Légaré; Deborah A Marshall; Meenakshi Bewtra
Journal:  Patient       Date:  2019-10       Impact factor: 3.883

2.  Issues in the Design of Discrete Choice Experiments.

Authors:  Richard Norman; Benjamin M Craig; Paul Hansen; Marcel F Jonker; John Rose; Deborah J Street; Brendan Mulhern
Journal:  Patient       Date:  2019-06       Impact factor: 3.883

3.  Patient Preferences in the Medical Product Lifecycle.

Authors:  Jennifer A Whitty; Esther W de Bekker-Grob; Nigel S Cook; Fern Terris-Prestholt; Michael Drummond; Rocco Falchetto; Hans L Hillege
Journal:  Patient       Date:  2020-02       Impact factor: 3.883

4.  Quantitative Preferences for Lung Cancer Treatment from the Patients' Perspective: A Systematic Review.

Authors:  Yasuo Sugitani; Naoko Sugitani; Shunsuke Ono
Journal:  Patient       Date:  2020-10       Impact factor: 3.883

5.  Do Patient Preferences Align With Value Frameworks? A Discrete-Choice Experiment of Patients With Breast Cancer.

Authors:  Ilene L Hollin; Juan Marcos González; Lisabeth Buelt; Michael Ciarametaro; Robert W Dubois
Journal:  MDM Policy Pract       Date:  2020-06-15

6.  Discrete Choice Experiments in Health Economics: Past, Present and Future.

Authors:  Vikas Soekhai; Esther W de Bekker-Grob; Alan R Ellis; Caroline M Vass
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.981

7.  The Patient Voice: Exploring Treatment Preferences in Participants with Mild Cognitive Concerns to Inform Regulatory Decision Making.

Authors:  Carol Mansfield; Kristin Bullok; Jillian Venci Fuhs; Antje Tockhorn-Heidenreich; J Scott Andrews; Dana DiBenedetti; Brandy R Matthews; Joshua C Darling; Jessie Sutphin; Brett Hauber
Journal:  Patient       Date:  2022-04-18       Impact factor: 3.481
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.